Background illustration for clinical trials search

Paid Clinical Trials Tennessee

Discover 1,846 paid clinical trials in Tennessee. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.

Filter
1

Study Evaluating the Safety, Tolerability, and Efficacy of Xaluritamig in Combination With Androgen Receptor Pathway Inhibitors in Participants With Metastatic Hormone-sensitive Prostate Cancer

for
Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
Location: Boston MA, Philadelphia PA, Myrtle Beach SC,
Sponsor: Amgen

Sex: Male

Age: 18+

Code: NCT07140900

Phase1, Recruiting

Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas

for
Atypical Teratoid/Rhabdoid Tumor,
Location: Hartford CT, Hackensack NJ, Hershey PA, Miami FL,
Sponsor: Milton S. Hershey Medical Center

Sex: All

Age: 0 - 26

Code: NCT06465199

Phase1, Phase2, Recruiting

A Study of mRNA-2808 in Participants With Relapsed or Refractory Multiple Myeloma

for
Relapsed or Refractory Multiple Myeloma
Location: Boston MA, New York NY, Philadelphia PA, Charlotte NC,
Sponsor: ModernaTX, Inc.

Sex: All

Age: 18+

Code: NCT07116616

Phase1, Phase2, Recruiting

Subcortical Arousal in Perceptual Awareness

for
Epilepsy
Location: Boston MA, New Haven CT, Lebanon NH, Nashville TN,
Sponsor: Yale University

Sex: All

Age: 13+

Code: NCT06934356

Recruiting

A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)

for
Rhabdomyosarcoma
Location: Bath ME, Portland ME, Scarborough ME, Sanford ME,
Sponsor: Children's Oncology Group

Sex: All

Age: 0 - 50

Code: NCT07466316

Phase3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Safety and Efficacy Long-Term Follow-up Study of Adult Participants Treated With Gene Modified T Cells

for
Long Term Safety Following GM T Cell Therapy
Location: Nashville TN
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06798298

Recruiting

Genetics of Charcot Marie Tooth (CMT) - Modifiers of CMT1A, New Causes of CMT2

for
Charcot-Marie-Tooth Disease, Type Ia (Disorder), HMSN
Location: Boston MA, Hartford CT, Philadelphia PA, Baltimore MD,
Sponsor: University of Iowa

Sex: All

Age: 0+

Code: NCT01193088

Recruiting

Natural History Evaluation of Charcot Marie Tooth Disease (CMT) Types CMT1B, CMT2A, CMT4A, CMT4C, and Others

for
Charcot Marie Tooth Disease
Location: Boston MA, Hartford CT, Philadelphia PA, Baltimore MD,
Sponsor: Michael Shy

Sex: All

Age: 0+

Code: NCT01193075

Recruiting

Robotic Versus Open Ventral Hernia Repair

for
Ventral Hernia
Location: Gainesville FL, Cleveland OH, Greenville SC,
Sponsor: Lucas Beffa

Sex: All

Age: 18+

Code: NCT05472987

Recruiting

A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer

for
HER2-positive Breast Cancer, Breast Cancer
Location: Scarborough ME, New York NY, East Brunswick NJ,
Sponsor: Jazz Pharmaceuticals

Sex: All

Age: 18+

Code: NCT07102381

Phase2, Recruiting

A Study to Assess the Efficacy and Safety of Empasiprubart in Adults With CIDP

for
Chronic Inflammatory Demyelinating Polyneuropathy, CIDP,
Location: Philadelphia PA, Washington D.C. DC, Miami FL,
Sponsor: argenx

Sex: All

Age: 18+

Code: NCT07091630

Phase3, Recruiting

High vs. Standard Dose Influenza Vaccines in Lung Transplant (Repeater)

for
Immunization; Infection|Transplantation Infection|Influenza,
Location: Nashville TN
Sponsor: Vanderbilt University Medical Center

Sex: All

Age: 18+

Code: NCT07192458

Phase2, Recruiting

A Study of Tarlatamab in Combination With AB248 in Participants With Extensive Stage Small Cell Lung Cancer (DeLLphi-311)

for
Extensive Stage Small Cell Lung Cancer
Location: Boston MA, New York NY, Philadelphia PA, Pittsburgh PA,
Sponsor: Amgen

Sex: All

Age: 18 - 70+

Code: NCT07037758

Phase1, Recruiting

A Dose-masked Study of Intravitreal EYE103 in Participants With NVAMD or Macular Edema Following BRVO

for
Neovascular Age-Related Macular Degeneration (NVAMD),
Location: Great Neck NY, Bloomfield NJ, Greenville NC,
Sponsor: EyeBiotech Ltd.

Sex: All

Age: 18+

Code: NCT07205887

Phase2, Recruiting

Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)

for
Ganglioneuroblastoma, Ganglioneuroblastoma, Nodular,
Location: St. John's, Halifax, Bangor ME, Scarborough ME,
Sponsor: Children's Oncology Group

Sex: All

Age: 1 - 30

Code: NCT03126916

Phase3, Recruiting

Improved Outcomes With Pre-Procedure Shockwave IVL of Common Femoral Artery Access Site Prior to Large Bore Access and Pre-Closure

for
Aortic Stenosis
Location: Knoxville TN
Sponsor: University of Tennessee Graduate School of Medicine

Sex: All

Age: 18+

Code: NCT07205068

Recruiting

A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors

for
Advanced/Metastatic Solid Tumors, Bladder Cancer,
Location: Boston MA, Newton MA, New Haven CT, Trumbull CT,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT07090499

Phase1, Recruiting

A Phase II Study With a Safety Run-In of the Addition of N-803 to a Chemoimmunotherapy Backbone for the Treatment of Patients With Relapsed or Refractory Neuroblastoma

for
Neuroblastoma Recurrent
Location: Philadelphia PA, Memphis TN
Sponsor: St. Jude Children's Research Hospital

Sex: All

Age: 0 - 30

Code: NCT07085338

Phase2, Recruiting

BEACON-1: Study of AVZO-103 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Urothelial Cancer or Other Solid Tumors (AVZO-103-1001)

for
Solid Tumor Cancer, Locally Advanced, Metastatic Solid Tumors,
Location: Boston MA, New York NY, Houston TX, Austin TX,
Sponsor: Avenzo Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT07193511

Phase1, Phase2, Recruiting

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

for
Crohn's Disease
Location: Boston MA, Providence RI, Worcester MA, New Haven CT,
Sponsor: Sanofi

Sex: All

Age: 16 - 70+

Code: NCT07184931

Phase3, Recruiting

Popular cities in Tennessee

MurfreesboroChattanoogaKnoxvilleNashvilleMemphis